Stock Updates

How has Medtronic plc:(NYSE:MDT) performed recently?

Medtronic plc (NYSE: MDT) is a large market cap stock with a market cap of 122407.25. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 35.35, a forward P/E of 16.98 and EPS of 2.48. At a stock price of 87.59 (-0.24%) it has a dividend yield of 1.96%.

EPS growth for the last five years have been -2.60%, more recently this last year it has grown by 2.90%. The next year growth is going to be about 11.01% and more long-term 7.84% after five years. EPS growth quarter over quarter is *TBA. Sales growth for the past five years have been 13.20% and sales growth quarter over quarter is 3.60%.

For performance, Medtronic plc the past week has seen a gain of 0.61%. For the last month performance for Medtronic plc is 1.01%. While the last quarter is 9.01% and half year, 16.03%. Finally for the year, performance is 25.75%.

The 52-week high for Medtronic plc, is at -1.88%, and for the 52-week low it comes to a value of 60.16%. The 20-day simple moving average is 0.98% and 10.65% for the 200-day simple moving average.

Volatility for the week is at 1.12%, and for the month it is 1.13%. Medtronic plc, has a target price of 90.66.

In terms of debt, long term debt/equity is 0.58, and for total debt/equity Medtronic plc has 0.6. The gross margin is 68.30%, while operating margin is 18.40%, the profit margin is 12.30%. The current ratio is 3.3 and the quick ratio is 2.8.

Insider ownership is at 0.10%, with instituitional ownership at 84.80%. Medtronic plc has a payout ratio of 60.50%. With the total shares outstanding coming to 1394.16. The shares float is 1389.16, with the float short at 0.98%, with short ratio coming to 2.9.

In terms of returns, the return on assets see Medtronic plc, get 3.40%, with its returns on investment at 5.40%. Return on equity is 6.80%. So will the investors see the target price of 90.66, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment